Healthcare - Biotechnology - NASDAQ - US
$ 42.18
-15.6 %
$ 5.03 B
Market Cap
-14.65
P/E
Price Target
Average
29.21%
Revenue Forecast
Estimate
205.32%
EBIT
Estimate
--37.03%
Net Income
Estimate
26.48%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Avidity Biosciences, Inc.
Wall Street analysts predict an average 1-year price target for RNA of $54.5 , with forecasts ranging from a low of $50 to a high of $59 .
RNA Lowest Price Target
Wall Street Target
50 USD
18.54%
RNA Average Price Target
Wall Street Target
54.5 USD
29.21%
RNA Highest Price Target
Wall Street Target
59 USD
39.88%
REVENUE FORECAST
Revenue Forecast Chart RNA
EBIT FORECAST
EBIT Forecast Chart RNA
NET INCOME FORECAST
Net Income Chart RNA